Content by James Strachan:

 Research Field Cancer

Cancer Static Shock

| James Strachan

Are the metrics used to measure cancer drug efficacy inherently flawed?

About the author

| Charlotte Barker, William Aryitey, Michael Schubert, James Strachan, Karim Dabbagh, Ann Hayes, Thomas Conrads, Anthony Quinn, Niclas Nilsson, Eric Topol, Benoit Arveiler, Didier Raoult, Ewan McNay, Tamara Minko, Jennifer Van Eyk, Cathy Merry, Diane Hoffman-Kim, Robert Coffin, Helen Lambert , Julian Solway, Richard Holland, Jan Johannessen, Ameeta Parekh, Bradley Hyman, Michela Gallagher

Research Field Animal models

Animal Alternatives

| James Strachan, Charlotte Barker

Could the lab rat be heading for retirement? A new breed of in vitro tissues and organs are being engineered to replace animal models – and the developers aim to make them accessible to all.
Research Field Metabolism & Diabetes

A Single-Edged Sword for Diabetes?

| James Strachan

Autocrine-based screening has identified a more selective anti-diabetic drug candidate
Tools & Techniques Biomedical engineering

Cellular Prostheses for Psoriasis

| James Strachan

Could cell-based synthetic circuits make pills and ointments a thing of the past for chronic disease?
Research Field Cell & gene therapy

Changing the Leopard’s Spots

| James Strachan

Holding back the “guardian of the genome” opens the gates to more efficient transdifferentiation
Research Field Neuroscience

From Astrophysics to Astrocytes

| James Strachan

A galaxy-mapping statistical model suggests that star-shaped astrocytes are repelled by Alzheimer’s plaques
Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register

October Issue of The Translational Scientist